Relmada Therapeutics
RLMD
#8408
Rank
ยฃ0.21 B
Marketcap
ยฃ2.00
Share price
-15.76%
Change (1 day)
-38.58%
Change (1 year)

EPS for Relmada Therapeutics (RLMD)

EPS in 2026 (TTM): -ยฃ0.69

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.71. In 2025 the company made an earnings per share (EPS) of -ยฃ1.11 an increase over its 2024 EPS that were of -ยฃ2.03.

EPS history for Relmada Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.69-37.68%
2025-ยฃ1.11-45.28%
2024-ยฃ2.03-19.21%
2023-ยฃ2.51-38.11%
2022-ยฃ4.05-25.98%
2021-ยฃ5.4787.93%
2020-ยฃ2.9139.05%
2019-ยฃ2.09-4.2%
2018-ยฃ2.1937.5%
2017-ยฃ1.59100%
2016-ยฃ0.79-87.56%
2015-ยฃ6.39
2013-ยฃ0.02415273.48%
2012-ยฃ0.006465

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cytokinetics
CYTK
-ยฃ4.62 549.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.93-231.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel